Literature DB >> 23537630

Dynamin 2 potentiates invasive migration of pancreatic tumor cells through stabilization of the Rac1 GEF Vav1.

Gina L Razidlo1, Yu Wang, Jing Chen, Eugene W Krueger, Daniel D Billadeau, Mark A McNiven.   

Abstract

The large GTPase Dynamin 2 (Dyn2) is markedly upregulated in pancreatic cancer, is a potent activator of metastatic migration, and is required for Rac1-mediated formation of lamellipodia. Here we demonstrate an unexpected mechanism of Dyn2 action in these contexts via direct binding to the Rac1 guanine nucleotide exchange factor (GEF) Vav1. Surprisingly, disruption of the Dyn2-Vav1 interaction targets Vav1 to the lysosome for degradation via an interaction with the cytoplasmic chaperone Hsc70, resulting in a dramatic reduction of Vav1 protein stability. Importantly, a specific mutation in Vav1 near its Dyn2-binding C-terminal Src homology 3 (SH3) domain prevents Hsc70 binding, resulting in a stabilization of Vav1 levels. Dyn2 binding regulates the interaction of Vav1 with Hsc70 to control the stability and subsequent activity of this oncogenic GEF. These findings elucidate how Dyn2 activates Rac1, lamellipod protrusion, and invasive cellular migration and provide insight into how this specific Vav is ectopically expressed in pancreatic tumors.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23537630      PMCID: PMC3905678          DOI: 10.1016/j.devcel.2013.02.010

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  52 in total

Review 1.  The dynamin family of mechanoenzymes: pinching in new places.

Authors:  M A McNiven; H Cao; K R Pitts; Y Yoon
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

Review 2.  Dynamin and its role in membrane fission.

Authors:  J E Hinshaw
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

Review 3.  Vav proteins, adaptors and cell signaling.

Authors:  X R Bustelo
Journal:  Oncogene       Date:  2001-10-01       Impact factor: 9.867

Review 4.  VAV proteins as signal integrators for multi-subunit immune-recognition receptors.

Authors:  Martin Turner; Daniel D Billadeau
Journal:  Nat Rev Immunol       Date:  2002-07       Impact factor: 53.106

5.  Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation.

Authors:  P De Sepulveda; S Ilangumaran; R Rottapel
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

6.  Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav.

Authors:  M López-Lago; H Lee; C Cruz; N Movilla; X R Bustelo
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

7.  Guanine exchange-dependent and -independent effects of Vav1 on integrin-induced T cell spreading.

Authors:  Miguel Angel del Pozo; Martin A Schwartz; Junru Hu; William B Kiosses; Amnon Altman; Martin Villalba
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

8.  Dynamin participates in focal extracellular matrix degradation by invasive cells.

Authors:  Massimiliano Baldassarre; Arsenio Pompeo; Galina Beznoussenko; Claudia Castaldi; Salvatore Cortellino; Mark A McNiven; Alberto Luini; Roberto Buccione
Journal:  Mol Biol Cell       Date:  2003-03       Impact factor: 4.138

9.  The haematopoietic specific signal transducer Vav1 is expressed in a subset of human neuroblastomas.

Authors:  Idit Hornstein; Eli Pikarsky; Maya Groysman; Gail Amir; Nili Peylan-Ramu; Shulamit Katzav
Journal:  J Pathol       Date:  2003-04       Impact factor: 7.996

10.  Regulated interactions between dynamin and the actin-binding protein cortactin modulate cell shape.

Authors:  M A McNiven; L Kim; E W Krueger; J D Orth; H Cao; T W Wong
Journal:  J Cell Biol       Date:  2000-10-02       Impact factor: 10.539

View more
  44 in total

Review 1.  Novel therapeutic targets for pancreatic cancer.

Authors:  Shing-Chun Tang; Yang-Chao Chen
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Dynamins 2 and 3 control the migration of human megakaryocytes by regulating CXCR4 surface expression and ITGB1 activity.

Authors:  Praveen K Suraneni; Seth J Corey; Michael J Hession; Rameez Ishaq; Arinola Awomolo; Shirin Hasan; Chirag Shah; Hui Liu; Amittha Wickrema; Najet Debili; John D Crispino; Elizabeth A Eklund; Yolande Chen
Journal:  Blood Adv       Date:  2018-12-11

3.  Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion.

Authors:  Gina L Razidlo; Christopher Magnine; Arthur C Sletten; Rachel M Hurley; Luciana L Almada; Martin E Fernandez-Zapico; Baoan Ji; Mark A McNiven
Journal:  Cancer Res       Date:  2015-05-14       Impact factor: 12.701

4.  Dynamin2 downregulation delays EGFR endocytic trafficking and promotes EGFR signaling and invasion in hepatocellular carcinoma.

Authors:  Chaojie Gong; Jubo Zhang; Lan Zhang; Yingcong Wang; Hui Ma; Weizhong Wu; Jiefeng Cui; Yanhong Wang; Zhenggang Ren
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

Review 5.  Phosphorylation-mediated regulation of GEFs for RhoA.

Authors:  Maulik Patel; Andrei V Karginov
Journal:  Cell Adh Migr       Date:  2013-01-01       Impact factor: 3.405

Review 6.  Regulating Rho GTPases and their regulators.

Authors:  Richard G Hodge; Anne J Ridley
Journal:  Nat Rev Mol Cell Biol       Date:  2016-06-15       Impact factor: 94.444

7.  TGFβ promotes mesenchymal phenotype of pancreatic cancer cells, in part, through epigenetic activation of VAV1.

Authors:  P-H Huang; P-J Lu; L-Y Ding; P-C Chu; W-Y Hsu; C-S Chen; C-C Tsao; B-H Chen; C-T Lee; Y-S Shan; C-S Chen
Journal:  Oncogene       Date:  2016-11-28       Impact factor: 9.867

8.  Vav1 as a central regulator of invadopodia assembly.

Authors:  Gina L Razidlo; Barbara Schroeder; Jing Chen; Daniel D Billadeau; Mark A McNiven
Journal:  Curr Biol       Date:  2013-12-12       Impact factor: 10.834

Review 9.  Dysfunction of chaperone-mediated autophagy in human diseases.

Authors:  Zhaozhong Liao; Bin Wang; Wenjing Liu; Qian Xu; Lin Hou; Jinlian Song; Qingming Guo; Ning Li
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

10.  Novel dynamin 2 mutations in adult T-cell acute lymphoblastic leukemia.

Authors:  Zheng Ge; Min Li; Gang Zhao; Lichan Xiao; Yan Gu; Xilian Zhou; Michael D Yu; Jianyong Li; Sinisa Dovat; Chunhua Song
Journal:  Oncol Lett       Date:  2016-08-10       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.